GZMB and hepatocellular carcinoma: In addition, the release of HSP90-Exs by human hepatocellular carcinoma cells has been shown to activate NK cell cytotoxicity, as well as granzyme B production, which is an important factor in the development of a positive tumor immune microenvironment (72).